Difference between revisions of "Mast Cells"
Rjfrancisrvc (talk | contribs) |
(Created page with '{| align="right" |<gallery> Image:LH Mast cell Histology.jpg|<p>'''Mast cell'''</p><sup>©Nottingham Uni 2008</sup> Image:LH Mast cells Histology.jpg|<p>'''Mast cells'''</p><sup>…') |
||
| (23 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | {| align="right" | |
| − | + | |<gallery> | |
| − | + | Image:LH Mast cell Histology.jpg|<p>'''Mast cell'''</p><sup>©Nottingham Uni 2008</sup> | |
| − | <p>Mast cells are derived from the same stem cell line as [[Basophils|basophils]] and while they are similar to basophils they are not identical. Mast cells are found in connective tissue and are larger than other | + | Image:LH Mast cells Histology.jpg|<p>'''Mast cells'''</p><sup>©Nottingham Uni 2008</sup> |
| + | </gallery> | ||
| + | |} | ||
| + | <p>Mast cells are derived from the same stem cell line as [[Basophils|basophils]] and while they are similar to [[Basophils|basophils]] they are not identical. Mast cells are found in connective tissue and are larger than other leukocytes at 15-20µm. They have cytoplasm containing a high number of large, intensely staining basophilic granules which mask the nucleus.</p> | ||
==Development== | ==Development== | ||
| − | <p>Mast cells | + | <p>Mast cells CFU develops in the [[Bone Marrow - Anatomy & Physiology|bone marrow]] from the myeloid set cell ([[Overview of Haematopoiesis - WikiBlood#Colony Forming Units|CFU-GEMM]]) under the stimulation of IL-3 and Stem Cell Factor. Then under the stimulation of Il-6 and SCF the immature mast cells are formed. These then enter circulation where they remain undifferentiated. On migration into tissue they then differentiate, under stimulation by Il-4, and produce their granules. Once in the tissue mast cells may last for weeks to months.</p> |
==Granules== | ==Granules== | ||
| Line 10: | Line 13: | ||
* Preformed mediators such as serotonin, histamine, proteoglycans, heparin and serine proteases (tryptase and/or chymase) | * Preformed mediators such as serotonin, histamine, proteoglycans, heparin and serine proteases (tryptase and/or chymase) | ||
* Lipid mediators such as leukotrienes and prostaglandin D2 | * Lipid mediators such as leukotrienes and prostaglandin D2 | ||
| − | * Cytokines: | + | * Cytokines: Il-3, Il-4, Il-5, Il-6, Il-8, Il-13, Il-16 TNF-α</p> |
| − | * Chemotactic factors for both [[Neutrophils|neutrophils]] and [[Eosinophils|eosinophils]] | + | *Chemotactic factors for both [[Neutrophils|neutrophils]] and [[Eosinophils|eosinophils]] |
<p>Histamine increases vascular permeability, mucous production and smooth muscle tone in the respiratory tract and is responsible for the itch sensation in the skin. Heparin is an anticoagulant and binds with antithrombin III and platelet factor IV to block coagulation factors. Leukotrienes like histamine are responsible for contraction of respiratory smooth muscle. Chymase plays a role in the production of angiotensin II.</p> | <p>Histamine increases vascular permeability, mucous production and smooth muscle tone in the respiratory tract and is responsible for the itch sensation in the skin. Heparin is an anticoagulant and binds with antithrombin III and platelet factor IV to block coagulation factors. Leukotrienes like histamine are responsible for contraction of respiratory smooth muscle. Chymase plays a role in the production of angiotensin II.</p> | ||
| − | <p> | + | <p>Granules are thought to produce a ground substance to facilitate collagen formation in repair of injury.</p> |
==Actions== | ==Actions== | ||
<p>Mast cells are involved in the inflammatory response and play a key part in anaphylaxis.</p> | <p>Mast cells are involved in the inflammatory response and play a key part in anaphylaxis.</p> | ||
| − | <p> | + | <p>IgE released by plasma cells in response to antigens bind to F<sub>C</sub> receptors on the mast cell surface. This stimulates the mast cells to degranulate. The granule contents cause blood vessel permeability to increase and, along with chemotactic factors, this enhances the migration of other leukocytes to the area. The production of angiotensin II by chymase causes systemic vasoconstriction in response to vascular damage.</p> |
==In pathology== | ==In pathology== | ||
| − | *Classically a cell involved in [[Acute Inflammation|acute inflammation]] | + | *Classically a cell involved in [[Acute Inflammation - Pathology|acute inflammation]] |
| − | * | + | *Mast cell tumours of the intestine and [[Mast Cell Tumour|liver]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==References== | ==References== | ||
<references /> | <references /> | ||
<br> | <br> | ||
| − | + | ---- | |
| − | [[ | + | <center><b><sup>Blood cells: [[Erythrocytes - WikiBlood|Erythrocytes]] | |
| + | [[Basophils|Basophils]], [[Eosinophils|Eosinophils]], [[Lymphocytes|Lymphocytes]], [[Macrophages|Macrophages]], [[Mast Cells - WikiBlood|Mast cells]], [[Monocytes|Monocytes]] & [[Neutrophils|Neutrophils]] | [[Thrombocytes|Thrombocytes]] & [[Thrombopoiesis - WikiBlood#Megakaryocyte|Megakaryocytes]]</sup></b></center> | ||
Revision as of 12:48, 12 June 2010
|
Mast cells are derived from the same stem cell line as basophils and while they are similar to basophils they are not identical. Mast cells are found in connective tissue and are larger than other leukocytes at 15-20µm. They have cytoplasm containing a high number of large, intensely staining basophilic granules which mask the nucleus.
Development
Mast cells CFU develops in the bone marrow from the myeloid set cell (CFU-GEMM) under the stimulation of IL-3 and Stem Cell Factor. Then under the stimulation of Il-6 and SCF the immature mast cells are formed. These then enter circulation where they remain undifferentiated. On migration into tissue they then differentiate, under stimulation by Il-4, and produce their granules. Once in the tissue mast cells may last for weeks to months.
Granules
Mast cells can be classified by the presence or lack of tryptase and/or chymase. MCTC mast cells have granules that contain tryptase and chymase (found mainly in skin and intestinal submucosa) while MCT mast cells have granules containing only tryptase (found mainly in respiratory tissue and intestinal mucosa). They can also be classified by their location within the body[1]. Mast cells in connective tissue are larger, have the proteoglycan heparin and contain high amounts of histamine while mucosal mast cells contain less histamine and have the proteoglycan chondroitin sulphate.
More generally the granules contain:
- Preformed mediators such as serotonin, histamine, proteoglycans, heparin and serine proteases (tryptase and/or chymase)
- Lipid mediators such as leukotrienes and prostaglandin D2
- Cytokines: Il-3, Il-4, Il-5, Il-6, Il-8, Il-13, Il-16 TNF-α
- Chemotactic factors for both neutrophils and eosinophils
Histamine increases vascular permeability, mucous production and smooth muscle tone in the respiratory tract and is responsible for the itch sensation in the skin. Heparin is an anticoagulant and binds with antithrombin III and platelet factor IV to block coagulation factors. Leukotrienes like histamine are responsible for contraction of respiratory smooth muscle. Chymase plays a role in the production of angiotensin II.
Granules are thought to produce a ground substance to facilitate collagen formation in repair of injury.
Actions
Mast cells are involved in the inflammatory response and play a key part in anaphylaxis.
IgE released by plasma cells in response to antigens bind to FC receptors on the mast cell surface. This stimulates the mast cells to degranulate. The granule contents cause blood vessel permeability to increase and, along with chemotactic factors, this enhances the migration of other leukocytes to the area. The production of angiotensin II by chymase causes systemic vasoconstriction in response to vascular damage.
In pathology
- Classically a cell involved in acute inflammation
- Mast cell tumours of the intestine and liver
References
- ↑ Metcalfe, D.D., Baram, D. and Mekori, Y. (1997) Mast Cells. Physiological Reviews 77(4): pp.1033-1064.